Malignant Melanoma With Neuroendocrine Differentiation: A Case Report and Literature Review
BackgroundMelanoma has a wide range of histologic variants and cytomorphologic features that make its diagnosis challenging. Melanoma can also rarely have neuroendocrine markers adding further diagnostic uncertainty particularly given that unrelated tumor types, such as prostate cancer, can also dis...
Saved in:
Main Authors: | Jason Cham, Ayal Shavit, Aren Ebrahimi, Miguel Viray, Paul Gibbs, Munveer S. Bhangoo |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5df484e4c2ba4f82b8daef6c02eb2f9d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of PD-1 Inhibitor Combined with Anlotinib on Advanced Neuroendocrine Carcinoma
by: YU Xuxu, et al.
Published: (2021) -
Progress of Immune Checkpoint Inhibitors
in the Treatment of Advanced Pulmonary Neuroendocrine Tumors
by: Haoqing CHEN, et al.
Published: (2021) -
Imaging of Neuroendocrine Prostatic Carcinoma
by: Ahmed Taher, et al.
Published: (2021) -
Melanoma in situ colonizing basal cell carcinoma: a case report and review of the literature
by: Silvia E. Mancebo, et al.
Published: (2015) -
Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities
by: Haider Mahdi, et al.
Published: (2021)